Arama

EISSN 2148-4279

EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL

European Journal of Rheumatology

PDF

HIGHLY CITED ARTICLES

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Sawalha, Amr H.; Manzi, Susan.

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

Crayne, Courtney; Cron, Randy Q.

The emerging role of lung ultrasound in COVID-19 pneumonia

Lepri, Gemma; Orlandi, Martina; Lazzeri, Chiara; Bruni, Cosimo; Hughes, Michael; Bonizzoli, Manuela; Wang, Yukai; Peris, Adriano; Matucci-Cerinic, Marco.

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

Krutzke, Sophia; Rietschel, Christoph; Horneff, Gerd.

New perspectives in the imaging of Raynaud's phenomenon

Herrick, Ariane L.; Dinsdale, Graham; Murray, Andrea.

The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis

Rosa, Irene; Romano, Eloisa; Fioretto, Bianca Saveria; Manetti, Mirko.

Pediatric Behcet's disease - clinical aspects and current concepts

Yildiz, Mehmet; Koker, Oya; Adrovic, Amra; Sahin, Sezgin; Barut, Kenan; Kasapcopur, Ozgur.

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Miossec, Pierre.

The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia

Cai, Ken; He, Jianna; Wong, Peter K. K.; Manolios, Nicholas.

Characteristics of coexisting localized scleroderma and inflammatory arthritis

Reiff, Daniel; Crayne, Courtney B.; Mannion, Melissa L.; Cron, Randy Q.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 8 results

Ranking

Release Date Sort Sort Article Type

Familial Mediterranean fever: An updated review

İsmail Sarı, Merih Birlik, Timuçin Kaşifoğlu

(Eur J Rheumatol 2014; 1: 21-33) DOI: 10.5152/eurjrheum.2014.006

Abstract Full Text (PDF) Related Articles

The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever

Sabri Güncan, N. Şule Y. Bilge, Döndü Üsküdar Cansu, Timuçin Kaşifoğlu, Cengiz Korkmaz

(Eur J Rheumatol 2016; 3: 118-121) DOI: 10.5152/eurjrheum.2016.16012

Abstract Full Text (PDF) Related Articles

Late ventricular potentials in familial Mediterranean fever with and without AA amyloidosis

Udi Nussinovitch, Avi Livneh

(Eur J Rheumatol 2017; 4: 184-188) DOI: 10.5152/eurjrheum.2017.16113

Abstract Full Text (PDF) Related Articles

Familial Mediterranean fever: An updated review

The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever

Late ventricular potentials in familial Mediterranean fever with and without AA amyloidosis

IL1-blocking therapy in colchicine-resistant familial Mediterranean fever

Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF

Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine

Evaluation of the controlling nutritional status score and prognostic nutritional index in patients with familial Mediterranean fever

Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression